NCT01443819

Brief Summary

The purpose of this research study is to look at two of the common forms of treatment for this condition: physical therapy and epidural steroid injection. The investigators are attempting to evaluate whether or not physical therapy alone, or epidural steroid injections alone, are effective in treating this condition. The investigators will also try to determine whether or not one of these treatments is better than the other for the treatment of herniated discs with nerve injury (radiculopathy).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started May 2011

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 26, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 30, 2011

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

June 30, 2022

Status Verified

June 1, 2022

Enrollment Period

1.8 years

First QC Date

September 26, 2011

Last Update Submit

June 29, 2022

Conditions

Keywords

RadiculopathyTransforaminalDisc Protrusion

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Score

    12months

Study Arms (3)

Lumbar Transforaminal Epidural Corticosteroid Injection

OTHER
Other: Lumbar Transforaminal Epidural Corticosteroid Injection

Physical Therapy

OTHER
Other: Physical Therapy

Cohort observational

OTHER
Other: Observation

Interventions

Injection: Anesthetic/corticosteroid (per randomization); repeat 1-3 times if clinically indicated. The following drugs will be used for this procedure: 80mg Depo-Medrol and 1% lidocaine. These drugs used for the epidural injections are local anesthetic numbing medicines and cortisone/steroid anti-inflammatory medicines.

Lumbar Transforaminal Epidural Corticosteroid Injection

Physical therapy carried out per protocol; 2-3 times per week for a total of 12 treatment sessions (excluding initial evaluation, including exit evaluation, minimum attendance 8/12) to be completed by 6 weeks from initiation of care (within study). Please note: There will be another PT evaluation at the end of 6 weeks.

Physical Therapy

If subject declines then inquire about enrolment in the observational cohort. Participants in this group (Cohort) will chose their treatment (per-protocol physical therapy, injections, or both) after consulting with their physicians.

Cohort observational

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Low back pain episode less than or equal to 12 weeks in duration, within the current pain episode. This may be the initial pain episode or the onset of a most recent episode of pain, preceded by at least a six month pain free interval.
  • Visual analog score (VAS) or screening Likert pain scale score three day average and present pain of at least four/ten at baseline.
  • Age 18 to 64.
  • Subjects will have focal disc herniation with unilateral radicular/neurological deficits or correlating radicular symptoms. These radicular symptoms/signs are defined as pain or paresthesias below the knee, pain reproduction with straight-leg-raising and/or extension or quadrant maneuvers, and radicular pattern sensory, reflex or strength changes. These symptoms will be consistent with their level of nerve root impingement and will primarily involve the L5 and/or S1 roots.
  • Those with canal and foraminal compromise due to disc herniation at L4-5 with L5 \> L4 signs and symptoms WILL be included.

You may not qualify if:

  • Litigation.
  • Workers compensation.
  • Those receiving remuneration for their pain, e.g. disability.
  • Back pain greater than leg pain.
  • Scoliosis of \> 15 degrees
  • Those unable to read English and complete the assessment instruments.
  • Spondylolysis, with or without spondylolithesis, degenerative spondylolithesis, or stenosis due primarily to degenerative bony or soft tissue changes.
  • Systemic inflammatory arthritis (e.g. rheumatoid, lupus).
  • Addictive behaviour, severe clinical depression, or psychotic features.
  • Significant lower extremity pathology that effects gait.
  • Sustained cervical or thoracic pain that is present at a level \>4/10 on VAS.
  • Possible pregnancy or other reason that precludes the use of fluoroscopy.
  • Prior lumbar surgery
  • Prior epidural steroid injections for treatment of current episode or within the prior year
  • Bilateral radicular signs/symptoms (\< 90% laterality of pain intensity or bilateral neurological signs)
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Spinal Diagnostics and Treatment Center

Daly City, California, 94015, United States

Location

Comprehensive Spine and Sport

Mill Valley, California, 94941, United States

Location

Stanford University Medicine Outpatient Center

Redwood City, California, 94063, United States

Location

MeSH Terms

Conditions

RadiculopathyIntervertebral Disc Displacement

Interventions

Physical Therapy ModalitiesObservation

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesSpinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationMethodsInvestigative Techniques

Study Officials

  • Matthew Smuck, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 26, 2011

First Posted

September 30, 2011

Study Start

May 1, 2011

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

June 30, 2022

Record last verified: 2022-06

Locations